Thomas Stankovich, Chief Financial Officer at ReShape Lifesciences Inc. (RSLS), sold 736,869 shares at $0.17 ($125K) on 2022-11-28, disclosed to the SEC on 2022-12-20.
Open-market sale of $125k RSLS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.17 | 364,756 | $62K | 49.6% |
| 2 | $0.17 | 364,756 | $62K | 49.6% |
| 3 | $0.15 | 2,213 | $332 | 0.3% |
| 4 | $0.15 | 5,144 | $772 | 0.6% |
| Total | $0.17 avg | 736,869 | $125K | 100% |
| Filing → |
| RSLS | SELL | 2023-07-19 | $156 | — | Filing → |
| RSLS | BUY | 2023-07-06 | $27K | — | Filing → |
| RSLS | SELL | 2023-07-06 | $746 | — | Filing → |